Brief: Epigenomics AG Execution Of A Biobank Sale Agreement And Update Of Guidance

New Horizon Health

17/08/2021 20:04

Aug 17 (Reuters) - Epigenomics Ag  ECXn.DE :
    * DGAP-ADHOC: EPIGENOMICS AG: EXECUTION OF A BIOBANK SALE
AGREEMENT AND UPDATE OF GUIDANCE
    * ENTERED INTO AN AGREEMENT WITH NEW HORIZON HEALTH LIMITED
ON
SALE OF CERTAIN NON-ESSENTIAL BIOLOGICAL SAMPLES
    * GROSS PROCEEDS FROM SALE ARE USD 6.7 MILLION
    * EPIGENOMICS-AS RESULT OF SALE, CO IS UPDATING ITS CURRENT
FY2021
REVENUE GUIDANCE TO APPROXIMATELY EUR 6.0 MILLION OF REVENUE
    * EXPECTS  EUR -3.0 MILLION TO EUR -4.0 MILLION OF EBITDA
BEFORE
SHARE-BASED PAYMENT EXPENSES IN 2021
    * CASH CONSUMPTION IN 2021 IS EXPECTED TO BE BETWEEN EUR 3.5
MILLION AND EUR 4.5 MILLION.

Source text for Eikon:  ID:nEQ7GKtpwa 
Further company coverage:  ECXn.DE 

 ((Reuters.Briefs@thomsonreuters.com;))